ClassID:

21496

A61K49/1806 - CPC Classification

Classification description:

Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes Suspensions, emulsions, colloids, dispersions

Sub-classes:
Recent Application in this class:
#1
20250213733
2025-07-03

EMULSION FOR ULTRASOUND ABLATION SURGERY

#2
20250135042
2025-05-01

Perfluorocarbon-Containing Contrast Agent for Use in MRI Imaging of Body Cavities

#3
20240124488
2024-04-18

AZA-CRYPTOPHANES, PROCESSES FOR PREPARATION THEREOF, AND THEIR USES

#4
20230355810
2023-11-09

Semifluorocarbon Compound Containing Contrast Agent

#5
20230102859
2023-03-30

NATURAL ORIGIN STABILIZER FOR OIL IN WATER EMULSIONS

#6
20220387634
2022-12-08

REDUCED METASTABLE COMPLEX MACROCYCLIC CONTRAST AGENTS

#7
20220273824
2022-09-01

CELL PENETRATING PEPTIDE FUNCTIONALIZED PERFLUOROCARBON NANOEMULSION COMPOSITIONS AND METHODS FOR IMAGING CELL POPULATIONS

#8
20220211879
2022-07-07

SOLVENT FREE GADOLINIUM CONTRAST AGENTS

#9
20220125955
2022-04-28

PER-ORAL NEGATIVE CONTRAST AGENT FOR ABDOMINAL IMAGING

#10
20220080058
2022-03-17

Reduced metastable complex macrocyclic contrast agents

#11
20220033424
2022-02-03

FLUOROUS METAL CHELATES COMPOSITIONS

#12
20210402012
2021-12-30

PARTICLE COMPRISING LANTHANIDE HYDROXIDE

#13
20210255257
2021-08-19

Ferromagnetic particles as ultra-sensitive non-linear response labels for magnetic particles imaging (MPI) and sensing applications

#14
20210252172
2021-08-19

Emulsion for ultrasound ablation surgery

#15
20210205479
2021-07-08

Compositions and methods for imaging cell populations

#16
20200384128
2020-12-10

Hydrogel-based nanoenulsion for selectively labeling cancer lesion, and preparation method therefor

#17
20200238242
2020-07-30

Process for the preparation of a suspension of nanosized synthetic zeolite materials, suspensions of nanosized synthetic zeolite materials obtained by said process and their uses in therapy and diagnosis

#18
20200197541
2020-06-25

GEL FORMULATIONS FOR GUIDING RADIOTHERAPY

#19
20200101014
2020-04-02

Stable Theranostic and Therapeutic Nanoemulsions Using Triphilic Semifluorinated Amphiphiles

#20
20200000942
2020-01-02

Per-oral negative contrast agent for abdominal CT

#21
20190365933
2019-12-05

Solvent-free gadolinium contrast agents

#22
20190269805
2019-09-05

SOLVENT-FREE GADOLINIUM CONTRAST AGENTS

#23
20190056463
2019-02-21

Ferromagnetic particles as ultra-sensitive non-linear response labels for magnetic particles imaging (MPI) and sensing applications

#24
20180369410
2018-12-27

Dendrimer-exosome hybrid nanoparticles as a delivery platform

#25
20180317886
2018-11-08

Method of detecting microbubbles in a vessel

#26
20180297857
2018-10-18

Aqueous Synthesis of Polyhedral "Brick-Like" Iron Oxide Nanoparticles for Hyperthermia and T2 MRI Contrast Enhancement, and for Targeting Endothelial Cells for Therapeutic Delivery

#27
20180185521
2018-07-05

Solvent-Free Gadolinium Contrast Agents

#28
20180126011
2018-05-10

Dendri-TAC and their use as theranostics

#29
20180028692
2018-02-01

Hypoosmotic Solutions for Lymph Node Detection

#30
20170196997
2017-07-13

RARE EARTH-BASED NANOPARTICLE MAGNETIC RESONANCE CONTRAST AGENT AND PREPARATION METHOD THEREOF

#31
20170173190
2017-06-22

Gadolinium expressed lipid nanoparticles for magnetic resonance imaging

#32
20170156628
2017-06-08

Magnetic resonance imaging methods for the study of gastrointestinal transit

#33
20160296640
2016-10-13

Bionanofluid for use as a contrast, imaging, disinfecting and/or therapeutic agent

#34
20160279273
2016-09-29

Microsphere comprising a lanthanide metal complex

#35
20160228582
2016-08-11

Pre-saturation of the liver and subsequent administration of the contrast agent

#36
20160166507
2016-06-16

NANOEMULSIONS OF HYDROPHOBIC PLATINUM DERIVATIVES

#37
20160089454
2016-03-31

Gel formulations for guiding radiotherapy

#38
20160000941
2016-01-07

Semifluorocarbon Compound Containing Contrast Agent

#39
20150320889
2015-11-12

Vectorised Magnetic Emulsion

#40
20150297758
2015-10-22

Magnetite in nanoparticulate form

#41
20150247008
2015-09-03

Chelating amphiphilic polymers

#42
20150030543
2015-01-29

Formulas for diagnosing and treating hormone-dependent cancers and cancers of the organs responsible for steroid hormone synthesis

#43
20140314679
2014-10-23

Hypoosmotic solutions for lymph node detection

#44
20140234224
2014-08-21

COMPOSITIONS AND METHODS FOR MOLECULAR IMAGING OF OXYGEN METABOLISM

#45
20140234223
2014-08-21

NANOEMULSIONS AND USE THEREOF AS CONTRAST AGENTS

#46
20140105829
2014-04-17

THERAPEUTIC NANOEMULSION FORMULATION FOR THE TARGETED DELIVERY OF DOCETAXEL AND METHODS OF MAKING AND USING THE SAME

#47
20130345780
2013-12-26

Conformally encapsulated multi-electrode arrays with seamless insulation

#48
20130343999
2013-12-26

Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications

#49
20130309176
2013-11-21

Chelate nanoemulsion for MRI

#50
20130280165
2013-10-24

Microsphere comprising a lanthanide metal complex

#51
20130045160
2013-02-21

Magnetic Nano-Composite for Contrast Agent, Intelligent Contrast Agent, Drug Delivery Agent for Simultaneous Diagnosis and Treatment, and Separation Agent for Target Substance

#52
20130022990
2013-01-24

Cellular labeling for nuclear magnetic resonance techniques

#53
20120269736
2012-10-25

Micellar compositions for use in biological applications

#54
20120251437
2012-10-04

Magnetite in nanoparticulate form

#55
20120114851
2012-05-10

Hyperpolarization methods, systems and compositions

#56
20120087857
2012-04-12

GADOLINIUM EXPRESSED LIPID NANOPARTICLES FOR MAGNETIC RESONANCE IMAGING

#57
20120059240
2012-03-08

METHOD FOR PREPARATION OF MICELLAR HYBRID NANOPARTICLES FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS AND COMPOSITIONS THEREOF

#58
20110177005
2011-07-21

Stable nanoemulsions for ultrasound-mediated drug delivery and imaging

#59
20110165074
2011-07-07

Chelating amphiphilic polymers

#60
20110142787
2011-06-16

Polymerized cyclic nitroxide radical compound and use thereof

#61
20110123438
2011-05-26

Universal anchor peptide for nanoparticles

#62
20110110867
2011-05-12

Multimodal imaging method using nano-emulsion comprising optical nano-particles and perfluorocarbons

#63
20110110863
2011-05-12

COMPOSITIONS AND METHODS FOR PRODUCING EMULSIONS FOR NUCLEAR MAGNETIC RESONANCE TECHNIQUES AND OTHER APPLICATIONS

#64
20110014124
2011-01-20

TARGETED ATHEROSCLEROSIS TREATMENT

#65
20100297022
2010-11-25

Magnetosome gene expression in eukaryotic cells

#66
20100254911
2010-10-07

Multimodal nanoparticles for non-invasive bio-imaging

#67
20100209352
2010-08-19

SYNTHESIS AND CONJUGATION OF IRON OXIDE NANOPARTICLES TO ANTIBODIES FOR TARGETING SPECIFIC CELLS USING FLUORESCENCE AND MR IMAGING TECHNIQUES

#68
20090324494
2009-12-31

MAGNETIC NANO-COMPOSITE FOR CONTRAST AGENT, INTELLIGENT CONTRAST AGENT, DRUG DELIVERY AGENT FOR SIMULTANEOUS DIAGNOSIS AND TREATMENT, AND SEPARATION AGENT FOR TARGET SUBSTANCE

#69
20090092554
2009-04-09

Encapsulated contrast agents

#70
20090074673
2009-03-19

Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques

#71
20090035223
2009-02-05

Biomimetic iron-oxide-containing lipoprotein and related materials

#72
20090016964
2009-01-15

HYPERPOLARIZATION METHODS, SYSTEMS AND COMPOSITIONS

#73
20080292554
2008-11-27

Cellular labeling for nuclear magnetic resonance techniques

#74
20080274053
2008-11-06

TISSUE METABOLIC STRESS MONITORING

#75
20080253960
2008-10-16

Lipoprotein-Based Nanoplatforms

#76
20080247943
2008-10-09

Blood Clot-Targeted Nanoparticles

#77
20080241123
2008-10-02

Amphiphilic nanotubes and micelles and method of delivery of biologically active agents

#78
20080241073
2008-10-02

Polymeric Micelle Type Mri Imaging Agent

#79
20080213181
2008-09-04

Preparation of Paramagnetic Nanoparticles Conjugated to Leukotriene B4 (LTB4) Receptor Antagonists, and Their Use as MRI Contrast Agents for the Detection of Infection and Inflammation

#80
20080145311
2008-06-19

Chelating agents with lipophilic carriers

#81
20080019904
2008-01-24

System For Manufacturing Micro-Sheres

#82
20070253899
2007-11-01

Dual function polymer micelles

#83
20070243136
2007-10-18

Methods and compositions for imaging

#84
20070202040
2007-08-30

Blood clot-targeted nanoparticles

#85
20070156046
2007-07-05

Method of enriching hyperpolarized atom nuclei and an apparatus for implementing the method

#86
20070154398
2007-07-05

Block copolymers and nano micelles comprising the same

#87
20070154397
2007-07-05

Thermosensitive nanostructure for hyperthermia treatment

#88
20070154396
2007-07-05

Block copolymers and nano micelles comprising the same

#89
20070110674
2007-05-17

SONO-ACTIVE LIPOSOMES AND LIPID PARTICLES AND USE THEREOF AS CONTRAST AGENTS AND ACTIVE-AGENT DELIVERY SYSTEMS

#90
20070086948
2007-04-19

Tissue metabolic stress monitoring

#91
20070059775
2007-03-15

Synthesis and conjugation of iron oxide nanoparticles to antibodies for targeting specific cells using fluorescence and MR imaging techniques

#92
20070010577
2007-01-11

Targeted atherosclerosis treatment

#93
20060293581
2006-12-28

Marker device for X-ray, ultrasound and MR imaging

#94
20060239919
2006-10-26

MR coronary angiography with a fluorinated nanoparticle contrast agent at 1.5 T

#95
20060099148
2006-05-11

Methods and compositions for imaging

#96
20060008417
2006-01-12

Lipophilic derivatives of chelate monoamides

#97
20050031544
2005-02-10

Receptor mediated nanoscale copolymer assemblies for diagnostic imaging and therapeutic management of hyperlipidemia and infectious diseases